share_log

Bionano Genomics Q2 2024 GAAP EPS $(0.24) Beats $(0.42) Estimate, Sales $7.771M Miss $8.003M Estimate

Benzinga ·  Aug 7 19:14

Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.42) by 42.86 percent. This is a 80.65 percent increase over losses of $(1.24) per share from the same period last year. The company reported quarterly sales of $7.771 million which missed the analyst consensus estimate of $8.003 million by 2.90 percent. This is a 10.29 percent decrease over sales of $8.662 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment